跳至主要内容
临床试验/PACTR202004540256535
PACTR202004540256535尚未招募3 期

Evaluation of the Impact on Childhood Mortality of Azithromycin Plus Intermittent Preventive Treatment Administered Through the Expanded Program on Immunization in Sierra Leone

Barcelona Institute for Global Health0 个研究点目标入组 20,560 人开始时间: 2020年1月17日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
20,560

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • Parents/guardians have signed the informed consent
  • Permanent residence in the study area-health facility catchment area
  • Without known allergies to or contraindications to macrolides
  • Without known allergies to or contraindications to SP
  • Agreement to complete the EPI scheme at the recruitment health facility
  • Parents/guardians agree to participate

排除标准

  • Residence outside the study area or planning to move out in the following 12 months from enrolment
  • Known history of allergy or contraindications to macrolides and/or SP
  • Known history of allergy or contraindications to SP
  • With signs of any acute illness at the time of recruitment
  • Participating in other intervention studies

研究者

相似试验